This document summarizes several research papers on using image processing and machine learning techniques to detect leukemia and classify its subtypes from blood smear images. Key techniques discussed include image segmentation using k-means clustering, marker-controlled watershed, and color-based methods. Features are then extracted from segmented cells and a support vector machine (SVM) classifier is used to detect leukemia subtypes such as ALL, AML, CLL, and CML. The goal of the research is to automate leukemia detection and classification.
Original Description:
this document is helpful to reveal different algorithms to detect leukemia affected cells.
Original Title
Abbstracts of Different Papers for Detection of Leukemia and Its Types Using Image Processing and Machine Learning
This document summarizes several research papers on using image processing and machine learning techniques to detect leukemia and classify its subtypes from blood smear images. Key techniques discussed include image segmentation using k-means clustering, marker-controlled watershed, and color-based methods. Features are then extracted from segmented cells and a support vector machine (SVM) classifier is used to detect leukemia subtypes such as ALL, AML, CLL, and CML. The goal of the research is to automate leukemia detection and classification.
This document summarizes several research papers on using image processing and machine learning techniques to detect leukemia and classify its subtypes from blood smear images. Key techniques discussed include image segmentation using k-means clustering, marker-controlled watershed, and color-based methods. Features are then extracted from segmented cells and a support vector machine (SVM) classifier is used to detect leukemia subtypes such as ALL, AML, CLL, and CML. The goal of the research is to automate leukemia detection and classification.
(Published in: 2017 International Conference on Trends in Electronics and Informatics (ICEI)
Date of Conference: 11-12 May 2017
Date Added to IEEE Xplore: 22 February 2018 ISBN Information: INSPEC Accession Number: 17564157 DOI: 10.1109/ICOEI.2017.8300983 Publisher: IEEE Conference Location: Tirunelveli, India) Abstract: Leukemia (blood cancer) begins in the bone marrow and causes the formation of a large number of abnormal cells. The most common types of leukemia known are Acute lymphoblastic leukemia (ALL), Acute myeloid leukemia (AML), Chronic lymphocytic leukemia (CLL) and Chronic myeloid leukemia (CML). This thesis makes an effort to devise a methodology for the detection of Leukemia using image processing techniques, thus automating the detection process. The dataset used comprises of 220 blood smear images of leukemic and non leukemic patients. The Image segmentation algorithms that have been used are k means clustering algorithm, Marker controlled watershed algorithm and HSV color based segmentation algorithm. The morphological components of normal and Leukemic lymphocytes differ significantly; hence various features have been extracted from the segmented lymphocyte images. The leukemia is further classified into its types and sub types by making use of the SVM classifier, which is a Machine Learning classifier. This thesis aims at detecting leukemia and determine whether it is AML, CML, CLL or ALL; thus taking the classification process one step further in the field of research, because most of the previous methods have been limited to the detection of leukemia or classifying it into one or two subtypes. Automatic detection of acute myeloid leukemia from microscopic blood smear image (Published in: 2017 International Conference on Advances in Computing, Communications and Informatics (ICACCI)
Date of Conference: 13-16 Sept. 2017
Date Added to IEEE Xplore: 04 December 2017 ISBN Information: INSPEC Accession Number: 17397690 DOI: 10.1109/ICACCI.2017.8126106 Publisher: IEEE Conference Location: Udupi, India) Abstract: Cancer of blood-forming tissues is called Leukemia. This disease hinders the body's ability to fight infection. Leukemia can be categorized into many types. Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML) are the two main types. The blood cells' growth and bone marrow are affected by AML. Collection of myeloid blasts in the bone marrow is one of the main characteristics of AML. In this research, a novel method is analyzed to detect the presence of AML. The paper proposes a technique that automatically detects and segments the nucleus from white blood cells (WBCs) in the microscopic blood smear images. Segmentation and clustering is done using a K-Means algorithm, while classification is done using Support Vector Machine (SVM) with feature reduction. Enhanced leukemia cancer classifier algorithm (Published in: 2014 Science and Information Conference
Date of Conference: 27-29 Aug. 2014
Date Added to IEEE Xplore: 09 October 2014 ISBN Information: INSPEC Accession Number: 14651032 DOI: 10.1109/SAI.2014.6918222 Publisher: IEEE Conference Location: London, UK) Abstract: The development of data mining applications such as classification and clustering has shown the need for machine learning algorithms to be applied to large scale data. Cancer classification has improved over the past 20 years; there has been no general approach for identifying new cancer classes or for assigning tumors to known classes (class prediction). Most proposed cancer classification methods are from the statistical and machine learning area, ranging from the old nearest neighbor analysis, to the new support vector machines. There is no single classifier that is superior over the rest. A generic approach to cancer classification based on gene expression monitoring by DNA microarrays is described and applied to human acute leukemia as a test case. A class discovery procedure automatically discovered the distinction between acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) with previous knowledge of these classes. There are two main objectives of this research, the first is to introduce the design and implementation of SMIG (Select Most Informative Genes) Algorithm, and the second objective is to design and Implement Enhanced Classification algorithm (ECA) system to enhance Leukemia cancer classification using SMIG module and ranking procedure. The proposed approach and experiments showed that after conducting the preprocessing and the classification using the proposed ECA system it can be reached in 0.1 s time the accuracy of 98% which is better when compared to previous techniques in previously published studies A review to detect leukemia cancer in medical images (Published in: 2016 International Conference on Computing, Communication and Automation (ICCCA)
Date of Conference: 29-30 April 2016
Date Added to IEEE Xplore: 16 January 2017 ISBN Information: INSPEC Accession Number: 16598762 DOI: 10.1109/CCAA.2016.7813896 Publisher: IEEE Conference Location: Noida, India) Abstract: Health informatics has been qualified as prominent province in the headway of information technology. Ascribable to such a sophisticated evolution in the health care informatics, it is viable at the present period of time to diagnose several ailments in a short span of time. In relation to complaints, there is one disease dub leukemia which can be recognised by manipulating different techniques of information technology. Leukemia customarily occurs when a big portion of nonstandard White Blood Cells produced in the body by bone-marrow. Hematologist makes usage of microscopic study of human blood-cells which leads towards the requirement of several different methods that consist of microscopic-images, segmentation process, grouping as well as classification that can allow proper identification of numerous distinct patients that are having leukemia disease. The image data-set of microscopic ridges would be inspected visually by using some hematologists as well as this process is quite time consuming along with exhausting. The well-timed and fast discovery of leukemia considerably aids in providingaptcure to the sick-patient. The necessity for computerization of detection of this disease generally rises perpetually since modern techniques that include proper manual-investigation of the tissues of the blood as primary step in the direction of disease diagnosis. This procedure is relatively time-consuming, along with their proper accurateness depend upon the proficiency of operator's. So, prevention of leukemia is quite important. This paper has surveyed several methods utilized by prior authors such as ANN (Artificial Neural Network), image processing, LDA (Linear Dependent Analysis), SOM (Self Organizing Map) etc. All-IDB: The acute lymphoblastic leukemia image database for image processing (Published in: 2011 18th IEEE International Conference on Image Processing
Date of Conference: 11-14 Sept. 2011
Date Added to IEEE Xplore: 29 December 2011 ISBN Information: ISSN Information: INSPEC Accession Number: 12504691 DOI: 10.1109/ICIP.2011.6115881 Publisher: IEEE Conference Location: Brussels, Belgium) Abstract: The visual analysis of peripheral blood samples is an important test in the procedures for the diagnosis of leukemia. Automated systems based on artificial vision methods can speed up this operation and increase the accuracy and homogeneity of the response also in telemedicine applications. Unfortunately, there are not available public image datasets to test and compare such algorithms. In this paper, we propose a new public dataset of blood samples, specifically designed for the evaluation and the comparison of algorithms for segmentation and classification. For each image in the dataset, the classification of the cells is given, as well as a specific set of figures of merits to fairly compare the performances of different algorithms. This initiative aims to offer a new test tool to the image processing and pattern matching communities, direct to stimulating new studies in this important field of research Detection of blood cancer in microscopic images of human blood samples: A review (Published in: 2016 International Conference on Electrical, Electronics, and Optimization Techniques (ICEEOT)
Date of Conference: 3-5 March 2016
Date Added to IEEE Xplore: 24 November 2016 ISBN Information: INSPEC Accession Number: 16487247 DOI: 10.1109/ICEEOT.2016.7754751 Publisher: IEEE Conference Location: Chennai, India) Abstract: For the fast and cost effective production of patient diagnosis, various image processing techniques or software has been developed to get desired information from medical images. Acute Lymphoblastic Leukemia (ALL) is a type of leukemia which is more common in children. The term `Acute' means that leukemia can progress quickly and if not treated may lead to fatal death within few months. Due to its non specific nature of the symptoms and signs of ALL leads wrong diagnosis. Even hematologist finds it difficult to classify the leukemia cells, there manual classification of blood cells is not only time consuming but also inaccurate. Therefore, early identification of leukemia yields in providing the appropriate treatment to the patient. As a solution to this problem the system propose individuates in the blood image the leucocytes from the blood cells, and then it selects the lymphocyte cells. It evaluates morphological index from those cells and finally it classifies the presence of leukemia. In this paper a literature review is been conducted on various techniques used for detecting cancer cells. All-IDB: The acute lymphoblastic leukemia image database for image processing (Published in: 2011 18th IEEE International Conference on Image Processing
Date of Conference: 11-14 Sept. 2011
Date Added to IEEE Xplore: 29 December 2011 ISBN Information: ISSN Information: INSPEC Accession Number: 12504691 DOI: 10.1109/ICIP.2011.6115881 Publisher: IEEE Conference Location: Brussels, Belgium) Abstract: The visual analysis of peripheral blood samples is an important test in the procedures for the diagnosis of leukemia. Automated systems based on artificial vision methods can speed up this operation and increase the accuracy and homogeneity of the response also in telemedicine applications. Unfortunately, there are not available public image datasets to test and compare such algorithms. In this paper, we propose a new public dataset of blood samples, specifically designed for the evaluation and the comparison of algorithms for segmentation and classification. For each image in the dataset, the classification of the cells is given, as well as a specific set of figures of merits to fairly compare the performances of different algorithms. This initiative aims to offer a new test tool to the image processing and pattern matching communities, direct to stimulating new studies in this important field of research. Automated detection of white blood cells cancer diseases (Published in: 2018 First International Workshop on Deep and Representation Learning (IWDRL)
Date of Conference: 29-29 March 2018
Date Added to IEEE Xplore: 14 May 2018 ISBN Information: INSPEC Accession Number: 17754719 DOI: 10.1109/IWDRL.2018.8358214 Publisher: IEEE Conference Location: Cairo, Egypt) Abstract: Automated diagnosis of white blood cells cancer diseases such as Leukemia and Myeloma is a challenging biomedical research topic. Our approach presents for the first time a new state of the art application that assists in diagnosing the white blood cells diseases. we divide these diseases into two categories, each category includes similar symptoms diseases that may confuse in diagnosing. Based on the doctor's selection, one of two approaches is implemented. Each approach is applied on one of the two diseases category by computing different features. Finally, Random Forest classifier is applied for final decision. The proposed approach aims to early discovery of white blood cells cancer, reduce the misdiagnosis cases in addition to improve the system learning methodology. Moreover, allowing the experts only to have the final tuning on the result obtained from the system. The proposed approach achieved an accuracy of 93% in the first category and 95% in the second category. A fuzzy based classifier for diagnosis of acute lymphoblastic leukemia using blood smear image processing Published in: 2017 5th Iranian Joint Congress on Fuzzy and Intelligent Systems (CFIS) Date of Conference: 7-9 March 2017 Date Added to IEEE Xplore: 18 August 2017 ISBN Information: INSPEC Accession Number: 17097687 DOI: 10.1109/CFIS.2017.8003589 Publisher: IEEE Conference Location: Qazvin, Iran Abstract: Leukemia is a kind of blood disorder and its early diagnosis plays an important role in preventing the rapid progression of the disease. The main objective of the research is how to use fuzzy concepts for deriving a proper classifier for diagnosis of this disorder in microscopic image of a patient's peripheral blood smears. Analysis of blood image usually results in early diagnosis of leukemia with lower costs. Furthermore, disease control and monitoring are possible at later stages using blood images. The use of pictures for diagnosis is less costly in terms of the equipment and material needed to detect the disease in comparison with other methods in the field of Hematology. The aim of this study is to identify characteristics of white blood cells and to detect the type of lymphoblasts using morphology method for the diagnosis of acute lymphoblastic leukemia. A set of 32 blood smears are used in this project and decisions concerning subtype of acute lymphoblastic leukemia are conducted based on the fuzzy system proposed in the paper. A degree of accuracy of 93.75% reflects better high performance of the proposed classifier. Interpretation of clinical endpoints in trials of acute myeloid leukemia Abstract Treatment regimens for acute myeloid leukemia (AML) have remained largely unchanged until recently. Molecular advances have opened the door to targeted therapies, many of which are in late-phase clinical trials. As new therapeutic opportunities arise, it is appropriate to review key aspects of clinical trial design, statistical interpretation of outcomes, and methods of data reporting. Complete remission and overall survival (OS) are common primary endpoints in early-phase AML clinical trials. OS and event-free survival are frequent primary endpoints in phase 3 trials. Clinical trials are designed to address the primary endpoint using prespecified α and power levels. Interpretation of additional endpoints (eg, secondary endpoints and subgroup analyses) must be viewed in light of a trial’s statistical design. Furthermore, variations in reporting of endpoints must be considered in order to understand trial outcomes. Time-to-event endpoints are typically reported using Kaplan-Meier curves, which are visually informative. Statistical data derived from these curves can be complex, and a variety of factors may impact interpretation. The purpose of this review is to discuss the nuances of common AML trial endpoints and their data presentation to better inform evaluation and understanding of clinical trial data.